Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04559893 · ClinicalTrials.gov registry record · NA
Collaboration Leading to Addiction Treatment and Recovery From Other Stresses
A NA study, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 729
- Enrollment target
NCT04559893: Completed NA study, sponsored by RAND.
NCT04559893 is a NA study that has completed, run by RAND. The registered enrollment target is 729 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04559893, a NA study, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 729 participants
- Enrollment target
Study Summary
Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO) is a five-year project that tests whether delivering care using a collaborative model helps patients with both opioid use disorders and mental health disorders.
Primary Outcome
Number of days until first buprenorphine prescription after study enrollment for study participants with a new episode of OUD care (no care for at least 30 days prior). Obtained from the Prescription Drug Monitoring Program and patient survey.
Interventions
- BEHAVIORAL Collaborative Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 729 participants |
| Start Date | 2021-01-08 |
| Est. Completion | 2024-06-12 |
| Phase | NA |
What the finished NCT04559893 record still lists
NCT04559893 is an interventional study that assigns participants to a tested intervention. The registered 729 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower).
The record links to 0 conditions, and to 1 intervention - of which Collaborative Care is the first listed.
NCT04559893 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04559893 about?
NCT04559893 is a clinical study titled "Collaboration Leading to Addiction Treatment and Recovery From Other Stresses". Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO) is a five-year project that tests whether delivering care using a collaborative model helps patients with both opioid use disorders and mental health disorders.
What is the current status of trial NCT04559893?
This trial is currently completed. It is a NA study. The enrollment target is 729 participants. The study started on 2021-01-08. Estimated completion is 2024-06-12.
What interventions are being tested in trial NCT04559893?
The interventions under investigation include: Collaborative Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT04559893?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04559893's enrollment target sits among peer trials
729 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03232918 · 730 participants · Phase 4
Oxytocin and Fetal Heart Rate Changes
- NCT05548283 · 730 participants · Phase 4
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- NCT07312162 · 730 participants
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
- NCT05065216 · 728 participants · Phase 2
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI